Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Sykes EnterprisesUnisysTelosNetScout SystemsSimulations Plus
SymbolNASDAQ:SYKENYSE:UISNASDAQ:TLSNASDAQ:NTCTNASDAQ:SLP
Price Information
Current Price$44.06$24.13$34.40$27.80$62.50
52 Week RangeBuyBuyBuyHoldBuy
MarketRank™
Overall Score1.41.01.71.22.0
Analysis Score1.50.03.51.03.4
Community Score2.02.34.62.62.4
Dividend Score0.00.00.00.01.7
Ownership Score1.71.70.01.70.8
Earnings & Valuation Score1.91.30.60.61.9
Analyst Ratings
Consensus RecommendationBuyBuyBuyHoldBuy
Consensus Price Target$44.00N/A$41.86$24.67$84.25
% Upside from Price Target-0.14% downsideN/A21.68% upside-11.27% downside34.80% upside
Trade Information
Market Cap$1.75 billion$1.62 billion$2.22 billion$2.04 billion$1.25 billion
Beta0.890.54N/A1.07-0.07
Average Volume150,690561,563826,975424,838209,918
Sales & Book Value
Annual Revenue$1.61 billion$2.95 billionN/A$891.82 million$41.59 million
Price / Sales1.080.55N/A2.2930.00
Cashflow$4.01 per share$5.17 per shareN/A$2.49 per share$0.65 per share
Price / Cash11.004.67N/A11.1895.51
Book Value$21.10 per share($19.69) per shareN/A$26.24 per share$7.92 per share
Price / Book2.09-1.23N/A1.067.89
Profitability
Net Income$64.08 million$-17,200,000.00N/A$-2,750,000.00$9.33 million
EPS$2.11N/AN/A$1.00$0.56
Trailing P/E Ratio33.381.650.0092.67122.55
Forward P/E Ratio14.99122.8625.2791.91
P/E Growth1.42N/AN/A5.638.45
Net Margins3.21%41.67%N/A2.61%22.74%
Return on Equity (ROE)12.31%-14.56%N/A4.77%10.65%
Return on Assets (ROA)7.72%2.66%N/A2.99%9.51%
Dividend
Annual PayoutN/AN/AN/AN/A$0.24
Dividend YieldN/AN/AN/AN/A0.38%
Three-Year Dividend GrowthN/AN/AN/AN/A14.29%
Payout RatioN/AN/AN/AN/A42.86%
Years of Consecutive Dividend GrowthN/AN/AN/AN/A1 Years
Debt
Debt-to-Equity Ratio0.01%N/AN/A0.23%N/A
Current Ratio1.97%1.73%N/A1.85%23.96%
Quick Ratio1.97%1.71%N/A1.78%23.45%
Ownership Information
Institutional Ownership Percentage88.73%98.65%N/A94.67%60.75%
Insider Ownership Percentage4.40%2.30%N/A4.36%24.45%
Miscellaneous
Employees54,90017,2007852,502129
Shares Outstanding39.61 million66.98 million64.63 million73.44 million19.97 million
Next Earnings Date5/3/2021 (Estimated)5/6/2021 (Confirmed)6/24/2021 (Estimated)5/6/2021 (Estimated)4/12/2021 (Confirmed)
OptionableOptionableOptionableNot OptionableOptionableOptionable
SourceHeadline
Simulations Pluss Earnings: A PreviewSimulations Plus's Earnings: A Preview
benzinga.com - April 9 at 2:45 PM
Simulations Plus, Inc.s (NASDAQ:SLP) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?Simulations Plus, Inc.'s (NASDAQ:SLP) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
finance.yahoo.com - April 8 at 1:18 PM
Simulations Plus Stock Is Estimated To Be Significantly OvervaluedSimulations Plus Stock Is Estimated To Be Significantly Overvalued
finance.yahoo.com - April 8 at 12:19 AM
Simulations Plus (SLP) to Post Q2 Earnings: What to Expect?Simulations Plus (SLP) to Post Q2 Earnings: What to Expect?
finance.yahoo.com - April 7 at 2:05 PM
Simulations Plus Reports Successful Results from AIDD Collaboration with Large Pharmaceutical CompanySimulations Plus Reports Successful Results from AIDD Collaboration with Large Pharmaceutical Company
finance.yahoo.com - April 7 at 9:04 AM
Simulations Plus (NASDAQ:SLP) Shares Gap Up to $63.03Simulations Plus (NASDAQ:SLP) Shares Gap Up to $63.03
americanbankingnews.com - April 6 at 11:02 AM
Zacks: Brokerages Anticipate Simulations Plus, Inc. (NASDAQ:SLP) Will Post Earnings of $0.14 Per ShareZacks: Brokerages Anticipate Simulations Plus, Inc. (NASDAQ:SLP) Will Post Earnings of $0.14 Per Share
americanbankingnews.com - April 3 at 10:10 AM
Should You Consider Simulations Plus (SLP) as Good Investment?Should You Consider Simulations Plus (SLP) as Good Investment?
finance.yahoo.com - April 2 at 7:47 AM
Simulations Plus Sets Date for Second Quarter Fiscal Year 2021 Earnings Release and Conference CallSimulations Plus Sets Date for Second Quarter Fiscal Year 2021 Earnings Release and Conference Call
finance.yahoo.com - March 29 at 4:53 PM
Simulations Plus Forms Scientific Advisory Board for RENAsym ConsortiumSimulations Plus Forms Scientific Advisory Board for RENAsym Consortium
finance.yahoo.com - March 16 at 12:52 PM
Simulations Plus Hosts the Inaugural 2021 MIDD+ Scientific Conference with over 50 Model-Informed Drug Development SessionsSimulations Plus Hosts the Inaugural 2021 MIDD+ Scientific Conference with over 50 Model-Informed Drug Development Sessions
finance.yahoo.com - March 11 at 10:12 AM
Simulations Plus to Present at Oppenheimer Healthcare ConferenceSimulations Plus to Present at Oppenheimer Healthcare Conference
finance.yahoo.com - March 9 at 9:43 AM
Notable Two Hundred Day Moving Average Cross - SLPNotable Two Hundred Day Moving Average Cross - SLP
nasdaq.com - March 4 at 3:54 PM
Simulations Plus and the University of Pittsburgh Drug Discovery Institute Receive SBIR Grant Funding for Large Molecule Safety CollaborationSimulations Plus and the University of Pittsburgh Drug Discovery Institute Receive SBIR Grant Funding for Large Molecule Safety Collaboration
finance.yahoo.com - February 23 at 12:44 PM
What We Learned About Simulations Plus (NASDAQ:SLP) CEO PayWhat We Learned About Simulations Plus' (NASDAQ:SLP) CEO Pay
finance.yahoo.com - February 22 at 3:23 PM
Simulations Plus to Participate in BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools ConferenceSimulations Plus to Participate in BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
finance.yahoo.com - February 11 at 2:24 PM
Simulations Plus Releases GastroPlus® Version 9.8.1Simulations Plus Releases GastroPlus® Version 9.8.1
finance.yahoo.com - February 9 at 9:02 AM
Simulations Plus Enters Agreement with Distributor in ChinaSimulations Plus Enters Agreement with Distributor in China
finance.yahoo.com - February 2 at 1:16 PM
Simulations Plus Expands Marketing and Sales Operations in South America Through Partnership with the Institute of Pharmaceutical SciencesSimulations Plus Expands Marketing and Sales Operations in South America Through Partnership with the Institute of Pharmaceutical Sciences
finance.yahoo.com - January 26 at 1:31 PM
Teladoc Reaches 80-Plus Relative Strength Rating BenchmarkTeladoc Reaches 80-Plus Relative Strength Rating Benchmark
finance.yahoo.com - January 26 at 1:31 PM
NASDAQ:SLP Investor Alert: Investigation over Potential Wrongdoing at Simulations Plus, Inc.NASDAQ:SLP Investor Alert: Investigation over Potential Wrongdoing at Simulations Plus, Inc.
sbwire.com - January 25 at 2:15 PM
Investigation announced for Investors in NASDAQ: SLP shares over potential Securities Laws Violations by Simulations Plus, Inc.Investigation announced for Investors in NASDAQ: SLP shares over potential Securities Laws Violations by Simulations Plus, Inc.
openpr.com - January 21 at 7:09 PM
Simulations Plus Awards Infrastructure Improvement Grant to Makerere University Department of Pharmacology and TherapeuticsSimulations Plus Awards Infrastructure Improvement Grant to Makerere University Department of Pharmacology and Therapeutics
finance.yahoo.com - January 14 at 7:14 PM
Simulations Plus (SLP) Stock Down Despite Q1 Earnings BeatSimulations Plus (SLP) Stock Down Despite Q1 Earnings Beat
nasdaq.com - January 13 at 2:03 PM
Simulations Plus Enters New Funded Collaboration to Improve Lung Exposure Models for Pulmonary Infection TreatmentsSimulations Plus Enters New Funded Collaboration to Improve Lung Exposure Models for Pulmonary Infection Treatments
finance.yahoo.com - January 12 at 3:14 PM
DateCompanyBrokerageAction
2/25/2021Sykes EnterprisesBarrington ResearchBoost Price Target
6/4/2020Sykes EnterprisesRobert W. BairdUpgrade
3/16/2020Sykes EnterprisesSidotiUpgrade
4/12/2019Sykes EnterprisesSunTrust BanksDowngrade
2/10/2020UnisysCanaccord GenuityReiterated Rating
12/12/2018UnisysLoop CapitalSet Price Target
4/1/2021TelosNeedham & Company LLCBoost Price Target
4/1/2021TelosWedbushBoost Price Target
3/26/2021TelosNorthland SecuritiesBoost Price Target
3/26/2021TelosDA DavidsonBoost Price Target
3/26/2021TelosB. RileyBoost Price Target
3/26/2021TelosBMO Capital MarketsBoost Price Target
12/14/2020TelosColliers SecuritiesInitiated Coverage
10/29/2020NetScout SystemsLake Street CapitalDowngrade
10/29/2020NetScout SystemsPiper SandlerUpgrade
5/8/2020NetScout SystemsRoyal Bank of CanadaBoost Price Target
10/11/2019NetScout SystemsPiper Jaffray CompaniesDowngrade
11/1/2018NetScout SystemsCraig HallumSet Price Target
1/12/2021Simulations PlusOppenheimerBoost Price Target
11/25/2020Simulations PlusTaglich BrothersUpgrade
10/16/2020Simulations PlusRaymond JamesInitiated Coverage
(Data available from 4/11/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.